CisplatinOxonic AcidTegafurFloxuridineFluorouracilDihydrouracil Dehydrogenase (NADP)Antimetabolites, AntineoplasticUridine PhosphorylaseDeoxycytidineThymidylate SynthasePyrimidine PhosphorylasesFluorodeoxyuridylateAntineoplastic Combined Chemotherapy ProtocolsDrug CombinationsOrotate PhosphoribosyltransferaseOrganoplatinum CompoundsAntineoplastic AgentsCamptothecinLeucovorinColorectal NeoplasmsAdministration, OralDrug Administration ScheduleStomach NeoplasmsUracilUridinePyrimidinesDrug Resistance, NeoplasmTreatment OutcomeThymidine PhosphorylaseAdenocarcinomaChemotherapy, AdjuvantDisease-Free SurvivalInfusions, IntravenousPentosyltransferasesNeoplasm MetastasisNeoplasm StagingSurvival RatePlatinumPyridinesSurvival AnalysisAntineoplastic Agents, PhytogenicProdrugsDose-Response Relationship, DrugColonic NeoplasmsTumor Cells, CulturedEtoposideLung NeoplasmsLiver NeoplasmsOvarian NeoplasmsDisease ProgressionCombined Modality TherapyTime FactorsVinblastineDNA AdductsPaclitaxelCell Line, TumorAntibodies, MonoclonalHead and Neck NeoplasmsCarboplatinIfosfamideVomitingCarcinoma, Squamous CellDrug Screening Assays, AntitumorCarcinoma, Non-Small-Cell LungDoxorubicinDrug SynergismTaxoidsApoptosisLeukopeniaTesticular NeoplasmsNauseaMitomycinVindesineCell SurvivalDNA DamageCarcinoma, Small CellNeutropeniaBleomycinNeoplasms, Germ Cell and EmbryonalDNA RepairGerminomaDrug EvaluationNeoplasm Recurrence, LocalDrug ResistanceEsophageal NeoplasmsMesotheliomaAntiemeticsNeoplasmsMaximum Tolerated DoseEpirubicinPleural NeoplasmsUrologic NeoplasmsThrombocytopeniaOndansetronMice, NudeAmifostineCarcinomaTumor Suppressor Protein p53GuanineCyclophosphamide